NEWS
|
Scientific publications by VitaK
Last week an invited review on the vital importance of vitamin K for public health was published in the American journal Advances in Nutrition 3 (2012) 166-173. In this paper we focus on the vascular aspects of vitamin K and its role in activating the vascular calcification inhibitor MGP. It has been demonstrated that in non-supplemented healthy adults MGP is incompletely activated, which forms an independent risk factor for arterial calcification. Extra intake of vitamin K may slow down or prevent the progress of age-related vascular stiffening. Population-based studies suggest that vitamin K2 is more effective in this respect than vitamin K1.
|
NEWS FLASHWednesday, 01 February 2012
Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects
In a recent study executed at VitaK laboratories we Read more...Thursday, 06 October 2011 New Vice-president appointed
Recently, VitaK has appointed Dr. Egbert Smit MBA as its new vice-president. Dr. Smit (39) studied Molecular Biology and Biotechnology at the Groningen University and Read more...Tuesday, 04 October 2011 High citation score of VitaK Research VitaK is proud to announce that our publication showing the beneficial effects of vitamin K2 on bone strength in postmenopausal women was one of the five mostly Read more...Thursday, 22 September 2011 VitaK BV is happy to announce three new employees. We will introduce them shortly for you! Jill Giera:
Jill Giera started in the function of Office Manager. She studied Director’s Management as well Read more...Saturday, 01 January 2011 Leon Schurgers leaves VitaK On January 1 st, 2011 Dr. Leon Schurgers, former vice-president of VitaK has left the company to continue his scientific career elsewhere in the University of Maastricht. Read more... |